Top Nutrition Coaching is fully dedicated to providing its readers with transparent, accurate, and compassionate information that applies to individuals from every demographic. Our nutritionists adhere to specific guidelines when creating content to ensure that all published materials are most advantageous to our readers. Top Nutrition Coaching has a no-tolerance policy regarding plagiarism.
All materials published by Top Nutrition Coaching adhere to the criteria outlined below:
Mounjaro and Ozempic compared by a registered dietitian — how they work, weight loss results, side effects, costs, and how to choose.
These days, you can't talk about weight loss without someone throwing Mounjaro or Ozempic into the conversation. Maybe it's friends, family, the news, or your doctor, but you're wondering what exactly the difference is, and whether you really need medication.
Both are injectable medications originally developed to treat type 2 diabetes, administered once weekly to help reduce appetite and promote weight loss.
Ozempic mimics a hormone that signals fullness, slows digestion, and helps your body manage blood sugar better. The drug is called semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, and was FDA-approved in 2017.
Mounjaro is the brand name for a similar drug called tirzepatide. Like Ozempic, it also activates GLP-1 receptors, but in addition, it also targets another one (GIP: gastric inhibitory polypeptide). This is another gut hormone that helps manage how you process food and hunger cues.
Mounjaro has become popular thanks to its dual-action mechanism, which can create a stronger effect on both blood sugar and body weight, compared to only GLP-1 medications.
A major trial that compared both drugs in adults with obesity without type 2 diabetes showed better results for tirzepatide. The trial went for 72 weeks, with patients on tirzepatide experiencing around 20% weight loss, with 14% for semaglutide (Ozempic). Nausea and diarrhea as side effects were common for both groups.
Another study analyzed real-world health data from 18,386 patients for about a year. Those on tirzepatide (Mounjaro) were about three times more likely to have a 15% or more reduction in body weight compared to those on semaglutide (Ozempic).
In general, the research supports tirzepatide (Mounjaro) leading to more weight loss for patients with obesity. However, that doesn't necessarily mean "better" since your needs and starting weight point are unique. It's always best to discuss what might work better for you with your doctor and RD (registered dietitian).
Like any medication, you can expect some side effects, such as
These typically happen when starting the medication or increasing the dose, and can die down with time.
Should you notice any side effects, like an allergic reaction, inability to keep liquids down for 12–24 hours, severe abdominal pain, or vision loss, call your emergency services.
There's always the chance of serious side effects, including:
There's also an official FDA "Boxed Warning" since both medications showed growth of thyroid tumors in rodent studies.
Naturally, these medications aren't cheap. They both run around $1,000 per month, but you can often get some or all of it covered by insurance if you have type 2 diabetes. If it's for weight loss alone, it may be a bit more difficult to get it covered.
There are a few manufacturer savings programs you can check out (Eli Lilly for Mounjaro and Novo Nordisk for Ozempic).
Fortunately, most insurance plans at least cover a registered dietitian for diabetes or weight loss management counseling. Check if your insurance covers a registered dietitian and get matched with a professional today.
Which medication is "best" is hard to answer; it depends on your health goals and starting point. For example, is it for diabetes, heart health, or weight loss alone? Ozempic, for example, also has FDA approval for reducing the risk of heart disease.
Which is right for you is up to you and your doctor, based on your medical history, other medications, and lifestyle.
Going into this conversation prepared makes a real difference. Think about asking:
Keep in mind that these medications only work while you're on them. That means your appetite and habits can return in full as soon as you stop taking them.
That's why it's so important to work with a weight loss registered dietitian. They go along the journey with you, helping you to develop healthier habits that you can maintain once you stop taking the drug. This is truly the key to long-term success and avoiding yo-yo weight loss throughout your lifetime.
The CDC also strongly recommends working on habit-development, which can feel much easier while you're on the medication. You'll have the benefit of momentum and excitement from seeing results, instead of the usual frustrations of crash dieting.
Managing weight with GLP-1 medications is more effective with nutrition support alongside it. Check if your insurance covers a registered dietitian — most plans do.
Mounjaro (tirzepatide) activates two hormone pathways (GLP-1 and GIP) while Ozempic (semaglutide) activates one (GLP-1). Both slow digestion and reduce appetite, but Mounjaro's dual mechanism produces greater average weight loss.
It depends on how you define "better." Mounjaro may lead to greater weight loss, but which medication is best depends on your needs and starting point.
Both can cause nausea, diarrhea, constipation, vomiting, and stomach pain — especially when starting or increasing the dose. More serious but rare side effects include pancreatitis, gallbladder problems, and a thyroid tumor risk flagged in animal studies.
They're similar at around $1,000 per month. Ozempic might be slightly cheaper, but it all depends on your insurance.
Yes, talk to your doctor if you're not happy with your results or side effects.

